Cargando…
Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependent
Based on their mechanism of action, two types of anti-CD20 antibodies are distinguished: Type I, which efficiently mediate complement-dependent cytotoxicity, and Type II, which instead are more efficient in inducing direct cell death. Several molecular characteristics of these antibodies have been s...
Autores principales: | Bondza, Sina, ten Broeke, Toine, Nestor, Marika, Leusen, Jeanette H. W., Buijs, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531561/ https://www.ncbi.nlm.nih.gov/pubmed/32744151 http://dx.doi.org/10.1080/19420862.2020.1792673 |
Ejemplares similares
-
Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength
por: Bondza, Sina, et al.
Publicado: (2021) -
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
por: Evers, Mitchell, et al.
Publicado: (2020) -
Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
por: Brandsma, Arianne M., et al.
Publicado: (2019) -
Real-time Characterization of Antibody Binding to Receptors on Living Immune Cells
por: Bondza, Sina, et al.
Publicado: (2017) -
Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
por: HAYLOCK, ANNA-KARIN, et al.
Publicado: (2015)